Psycheceutical Bioscience IncOver The Counter Market:BWVI
- LAST PRICE0.0001
- TODAY'S CHANGE (%)0.0000 (0.0000%)
- Bid / Lots---/ ---
- Ask / Lots---/ ---
- Open / Previous Close--- / 0.0001
- Day Range---
- 52 Week Range
- Volume---
Search Criteria
Filter search criteria using below inputs
Click on magnifying glass icon to search
| Company | Country | Symbol |
|---|
| Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
|---|---|---|---|
Psycheceutical Bioscience Inc | 27.6K | 0.0x | --- |
Health Discovery Corp | 410.0 | 0.0x | --- |
Evolutionary Genomics Inc | 5.3K | 0.0x | --- |
Anthera Pharmaceuticals Inc | 2.6K | 0.0x | --- |
eFFECTOR Therapeutics Inc | 940.0 | 0.0x | --- |
Regnum Corp | 20.0 | 0.0x | --- |
Company Information
Psycheceutical Bioscience, Inc. is a bioscience company. The Company is engaged in developing cutting-edge delivery technologies to support safe psychedelic pharmaceutical medicines. The Company's technology is intended to deliver compounds across the blood-brain barrier while bypassing the gastrointestinal (GI) tract and liver, eliminating hallucinogenic effects and vastly reducing exposure to drug toxicities and side effects. The Company's systematic delivery system is designed to use extremely small multi-layered compounds, called Janus particles, to deliver targeted doses of any psychedelic compound directly through the blood-brain barrier, thereby bypassing the liver and reducing toxicity and side effects. The Company's NeuroDirect topical delivery system is a non-systemic delivery technology designed to deliver neuro-active compounds directly into the nerve tissue through topical application at the back of the neck.
Contact Information
- Headquarters
- 1765 Country Walk DriveFLEMING ISLAND, FL, United States 32003
- Phone
- 904-215-7601
- Fax
- 702-866-2689
Executives
- Executive Chairman of the Board, Chief Executive Officer
- Neilank Jha
- Chief Financial Officer
- Alan Parks
- Chief Operating Officer
- Chad Harman
- Director - Business Development
- John Arnone
- Executive Assistant and Logistics Director
- Elizabeth Weeks-Webb
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $27.6K |
|---|---|
Revenue (TTM) | $1.2M |
Shares Outstanding | 276.4M |
Psycheceutical Bioscience Inc does not pay a dividend. | |
Beta | 1.45 |
EPS | $-0.12 |
Book Value | $0.00 |
P/E Ratio | 0.0x |
Price/Sales (TTM) | 0.0 |
Price/Cash Flow (TTM) | --- |
Operating Margin | -15.67% |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.
